how many glp 1 drugs are there America's Poison Centers Understanding GLP-1 Agonists: Key Insights

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

Beyond these frontrunners, the pipeline is expanding: Novo Nordisk filed for FDA approval of CagriSema in 2025, the first once-weekly combination of GLP1 and amylin analogue

Please use caution if you have allergies or sensitivities to any of the listed ingredients

Lose weight & control blood sugar

Clinician-written guides on GLP-1s, phentermine, metabolism, safe weight loss, and progress tracking

Supports overall daily wellness